Product logins

Find logins to all Clarivate products below.


  • The number of total prevalent cases of SAD in the countries under study will increase by 7% from 21 million to 23 million in 20 years.
  • Of the countries considered in this analysis, the total prevalence of SAD is highest in the United States at 63 per 1,000.
  • The average age of all total prevalent cases of SAD in the countries under study is 41.
  • 56% of all total prevalent cases of SAD in the countries under study are female.

Related Market Assessment Reports

Report
Schizophrenia – Current Treatment – Treatment Algorithms: Claims Data Analysis – Schizophrenia (US)
Schizophrenia is a highly drug-treated condition that uses an array of medications, including atypical and typical antipsychotics, resulting in a complex treatment algorithm. Although this drug…
Report
Bipolar Disorder – Current Treatment – Current Treatment: Physician Insights – Bipolar Disorder (EU5)
Bipolar disorder (BD) is a spectrum disorder characterized by recurrent episodes of aberrant mood; patients may exhibit manic, depressive, or mixed symptoms between periods of stable mood. Lithium…
Report
Ulcerative Colitis – Epidemiology – Epidemiology – Ulcerative Colitis – Mature Markets
Clarivate Epidemiology’s coverage of ulcerative colitis (UC) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence…
Report
Emerging Vaccines – Epidemiology – Epidemiology – Emerging Vaccines- Mature Markets
Clarivate Epidemiology’s coverage of emerging vaccines comprises epidemiological estimates of eligible populations in the major mature pharmaceutical markets (United States, France, Germany,…
Report
Eosinophilic Esophagitis – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of eosinophilic esophagitis (EoE) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States…